Progressive relapsing multiple sclerosis and Speech disorder
Summary:
Speech disorder is found among people with Progressive relapsing multiple sclerosis, especially for people who are female, 20-29 old.
The study analyzes which people have Speech disorder with Progressive relapsing multiple sclerosis. It is created by eHealthMe based on reports of 11 people who have Progressive relapsing multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Progressive relapsing multiple sclerosis?
Progressive relapsing multiple sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord or both) is found to be associated with 17 drugs and 38 conditions by eHealthMe. Check the latest studies of Progressive relapsing multiple sclerosis.
What is Speech disorder?
Speech disorder is found to be associated with 1,809 drugs and 2,275 conditions by eHealthMe. Check the latest studies of Speech disorder.
11 people who have Progressive Relapsing Multiple Sclerosis and Speech Disorder are studied.

Gender of people who have Progressive Relapsing Multiple Sclerosis and experienced Speech Disorder *:
- female: 63.64 %
- male: 36.36 %
Age of people who have Progressive Relapsing Multiple Sclerosis and experienced Speech Disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 40 %
- 30-39: 20 %
- 40-49: 10 %
- 50-59: 0.0 %
- 60+: 30 %
Common co-existing conditions for these people *:
- Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 4 people, 36.36%
- Type 2 Diabetes: 1 person, 9.09%
- High Blood Pressure: 1 person, 9.09%
Common drugs taken by these people *:
- Ocrevus: 5 people, 45.45%
- Vitamin D3: 4 people, 36.36%
- Vitamin B12: 4 people, 36.36%
- Tysabri: 3 people, 27.27%
- Rebif: 2 people, 18.18%
- Plavix: 1 person, 9.09%
- Metformin: 1 person, 9.09%
- Janumet Xr: 1 person, 9.09%
- Gilenya: 1 person, 9.09%
- Diovan: 1 person, 9.09%
Common symptoms for these people *:
- Fall: 4 people, 36.36%
- Gait Disturbance: 4 people, 36.36%
- Balance Disorder: 4 people, 36.36%
- Visual Acuity Reduced (reduced clearness of vision): 4 people, 36.36%
- Fatigue (feeling of tiredness): 4 people, 36.36%
- Consciousness - Decreased: 3 people, 27.27%
- Infusion Related Reaction: 3 people, 27.27%
- Malaise (a feeling of general discomfort or uneasiness): 3 people, 27.27%
- Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 27.27%
- Cystitis Noninfective (non-infectious inflammation of the wall of the bladder): 3 people, 27.27%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Speech disorder?
- Check whether Speech disorder is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Progressive relapsing multiple sclerosis (526 reports)
- Speech disorder (62,574 reports)
All the drugs that are associated with Speech disorder:
- Speech disorder (1,809 drugs)
All the conditions that are associated with Speech disorder:
- Speech disorder (2,275 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Speech disorder and Progressive relapsing multiple sclerosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Pepcid cause Dyspnea Exertional? - 12 seconds ago
- Could Donepezil Hydrochloride cause Diabetes Mellitus Aggravated? - 15 seconds ago
- Drug interactions of Cymbalta and Sodium Fluoride - 19 seconds ago
- Could Januvia cause Feeling Cold? - 27 seconds ago
- Could Zetia cause High Blood Cholesterol? - 33 seconds ago
- Could Sulfasalazine cause Renal Tubular Necrosis? - 47 seconds ago
- Could Warfarin Sodium cause Blood Potassium Abnormal? - 48 seconds ago
- Could Lantus cause Fluid Overload? - 49 seconds ago
- Could Xpovio cause Renal Function Test Abnormal? - a minute ago
- Could Azilect cause Urination - Painful? - a minute ago